Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adeptrix, Avacta Group, Babson Diagnostics, Biolife Solutions, Biosig Technologies, Co-Diagnostics, Dermtech, Ipsum Diagnostics, Omega Bio-tek, Quantumdx Group Tandem Diabetes Care, Trinetx, Viewray.

Med-tech firms raising money in public or private financings, including: Pulse Biosciences, Second Sight Medical Products.

New hires and promotions in the med-tech industry, including: Blue Earth Diagnostics, Intricon.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acceleron, Alexion, BMS, Essa, Galectin, Genmab, Novan, Novartis, Pierre Fabre, PTC, Sosei, Telix, Vertex.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: ADC, Agex, Aradigm, Bixink, Coimmune, Enzychem, Evergreen, Formula, Gilead, Inovio, Lixte, Lonza, Moderna, Oxford Biodynamics, Puma, Teva, Vivus, Xbiotech.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Akari, Astrazeneca, Athersys, Azurrx, BMS, Calcimedica, Eiger, Flexion, Ipsen, Kubota, Lilly, Merck, Novartis, Synairgen, TG.

Biopharmas raising money in public or private financings, including: Acer, Achieve, Aeglea, Algernon, Alume, IMV, Lyra, Neubase.

Quarterly snapshots from biopharma companies with marketed products, including: Amgen, Gilead, Seattle Genetics.

New hires and promotions in the biopharma industry, including: Gritstone, Horizon, Viela.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Binx Health, Cerus Endovascular, Nines, Refine USA, Rheonix, Synaptive Medical.